MMWR Recomm Rep. 1991 Apr 19;40(RR-4):21-3.
CDC has recently reviewed data on the reported incidence in the United States of Plasmodium falciparum malaria and has evaluated available information on the effective management of severe life-threatening infections. As a result of this review, CDC has concluded that the therapeutic drug of choice in the United States for persons with complicated P. falciparum infection is parenteral quinidine gluconate, and that stocking of parenteral quinine dihydrochloride for emergency distribution is no longer required to provide optimal management of P. falciparum infections.
美国疾病控制与预防中心（CDC）最近审查了美国恶性疟原虫疟疾报告发病率的数据，并评估了有关严重危及生命感染有效管理的现有信息。经过此次审查，CDC得出结论，在美国，对于患有复杂恶性疟原虫感染的患者，首选治疗药物是胃肠外注射葡萄糖酸奎尼丁，并且不再需要储备胃肠外注射二盐酸奎宁用于紧急分发，以实现对恶性疟原虫感染的最佳管理。
